rs12076297

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_005076.5(CNTN2):​c.178G>A​(p.Ala60Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00209 in 1,613,400 control chromosomes in the GnomAD database, including 68 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A60V) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.012 ( 35 hom., cov: 32)
Exomes 𝑓: 0.0011 ( 33 hom. )

Consequence

CNTN2
NM_005076.5 missense

Scores

1
17

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 1.15

Publications

5 publications found
Variant links:
Genes affected
CNTN2 (HGNC:2172): (contactin 2) This gene encodes a member of the contactin family of proteins, part of the immunoglobulin superfamily of cell adhesion molecules. The encoded glycosylphosphatidylinositol (GPI)-anchored neuronal membrane protein plays a role in the proliferation, migration, and axon guidance of neurons of the developing cerebellum. A mutation in this gene may be associated with adult myoclonic epilepsy. [provided by RefSeq, Sep 2016]
CNTN2 Gene-Disease associations (from GenCC):
  • complex neurodevelopmental disorder
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • epilepsy, familial adult myoclonic, 5
    Inheritance: AR Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
  • benign adult familial myoclonic epilepsy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0070005357).
BP6
Variant 1-205058028-G-A is Benign according to our data. Variant chr1-205058028-G-A is described in ClinVar as Benign. ClinVar VariationId is 474469.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.0117 (1775/152278) while in subpopulation AFR AF = 0.0406 (1686/41556). AF 95% confidence interval is 0.039. There are 35 homozygotes in GnomAd4. There are 841 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 35 AR,AD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CNTN2NM_005076.5 linkc.178G>A p.Ala60Thr missense_variant Exon 3 of 23 ENST00000331830.7 NP_005067.1 Q02246A1ML24A1L3A3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CNTN2ENST00000331830.7 linkc.178G>A p.Ala60Thr missense_variant Exon 3 of 23 1 NM_005076.5 ENSP00000330633.4 Q02246

Frequencies

GnomAD3 genomes
AF:
0.0116
AC:
1766
AN:
152160
Hom.:
34
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0405
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00386
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.000103
Gnomad OTH
AF:
0.0100
GnomAD2 exomes
AF:
0.00294
AC:
737
AN:
250328
AF XY:
0.00219
show subpopulations
Gnomad AFR exome
AF:
0.0422
Gnomad AMR exome
AF:
0.00127
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000265
Gnomad OTH exome
AF:
0.00115
GnomAD4 exome
AF:
0.00109
AC:
1590
AN:
1461122
Hom.:
33
Cov.:
32
AF XY:
0.000944
AC XY:
686
AN XY:
726842
show subpopulations
African (AFR)
AF:
0.0405
AC:
1353
AN:
33442
American (AMR)
AF:
0.00166
AC:
74
AN:
44668
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26110
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39664
South Asian (SAS)
AF:
0.0000696
AC:
6
AN:
86180
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53268
Middle Eastern (MID)
AF:
0.00104
AC:
6
AN:
5762
European-Non Finnish (NFE)
AF:
0.0000162
AC:
18
AN:
1111692
Other (OTH)
AF:
0.00220
AC:
133
AN:
60336
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.484
Heterozygous variant carriers
0
90
179
269
358
448
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
44
88
132
176
220
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0117
AC:
1775
AN:
152278
Hom.:
35
Cov.:
32
AF XY:
0.0113
AC XY:
841
AN XY:
74458
show subpopulations
African (AFR)
AF:
0.0406
AC:
1686
AN:
41556
American (AMR)
AF:
0.00386
AC:
59
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5176
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4830
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10630
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.000103
AC:
7
AN:
67990
Other (OTH)
AF:
0.00993
AC:
21
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
90
180
269
359
449
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00466
Hom.:
19
Bravo
AF:
0.0133
ESP6500AA
AF:
0.0427
AC:
188
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.00380
AC:
461
Asia WGS
AF:
0.00144
AC:
5
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Epilepsy, familial adult myoclonic, 5 Benign:1
Feb 02, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.13
BayesDel_addAF
Benign
-0.70
T
BayesDel_noAF
Benign
-0.75
CADD
Benign
19
DANN
Uncertain
1.0
DEOGEN2
Benign
0.054
T;T;.
Eigen
Benign
-0.45
Eigen_PC
Benign
-0.18
FATHMM_MKL
Benign
0.53
D
LIST_S2
Benign
0.77
.;.;T
MetaRNN
Benign
0.0070
T;T;T
MetaSVM
Benign
-0.97
T
MutationAssessor
Benign
-1.2
N;N;.
PhyloP100
1.2
PrimateAI
Benign
0.34
T
PROVEAN
Benign
1.1
.;N;.
REVEL
Benign
0.055
Sift
Benign
0.14
.;T;.
Sift4G
Benign
1.0
.;T;.
Polyphen
0.0040
B;B;.
Vest4
0.094
MVP
0.61
MPC
0.41
ClinPred
0.012
T
GERP RS
5.4
Varity_R
0.12
gMVP
0.40
Mutation Taster
=81/19
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs12076297; hg19: chr1-205027156; COSMIC: COSV99045549; COSMIC: COSV99045549; API